BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34097171)

  • 1. Radiation Necrosis from Stereotactic Radiosurgery-How Do We Mitigate?
    Vellayappan BA; McGranahan T; Graber J; Taylor L; Venur V; Ellenbogen R; Sloan AE; Redmond KJ; Foote M; Chao ST; Suh JH; Chang EL; Sahgal A; Lo SS
    Curr Treat Options Oncol; 2021 Jun; 22(7):57. PubMed ID: 34097171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.
    Sharma A; Mountjoy LJ; Butterfield RJ; Zhang N; Ross HJ; Schild SE; Sio TT; Daniels TB; Paripati HR; Mrugala MM; Vora SA; Patel NP; Zimmerman RS; Ashman JB; Porter AB
    Am J Clin Oncol; 2020 Feb; 43(2):128-132. PubMed ID: 31764021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases.
    Sayan M; Şahin B; Mustafayev TZ; Kefelioğlu EŞS; Vergalasova I; Gupta A; Balmuk A; Güngör G; Ohri N; Weiner J; Karaarslan E; Özyar E; Atalar B
    Neurocirugia (Astur : Engl Ed); 2021; 32(6):261-267. PubMed ID: 34743823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases.
    Mayo ZS; Billena C; Suh JH; Lo SS; Chao ST
    Neuro Oncol; 2024 Mar; 26(12 Suppl 2):S56-S65. PubMed ID: 38437665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.
    Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C
    Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations.
    Vellayappan B; Lim-Fat MJ; Kotecha R; De Salles A; Fariselli L; Levivier M; Ma L; Paddick I; Pollock BE; Regis J; Sheehan JP; Suh JH; Yomo S; Sahgal A
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):14-28. PubMed ID: 37482137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.
    Tanenbaum DG; Buchwald ZS; Jhaveri J; Schreibmann E; Switchenko JM; Prabhu RS; Chowdhary M; Abugideiri M; Pfister NT; Eaton B; Kahn SE; Olson JJ; Shu HG; Crocker IR; Curran WJ; Patel KR
    Pract Radiat Oncol; 2020; 10(1):36-43. PubMed ID: 31586666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.
    Stockham AL; Ahluwalia M; Reddy CA; Suh JH; Kumar A; Vogelbaum MA; Barnett GH; Murphy ES; Chao ST
    J Neurooncol; 2013 Dec; 115(3):469-75. PubMed ID: 24045970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
    Donovan EK; Parpia S; Greenspoon JN
    Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis.
    Palmer JD; Perlow HK; Matsui JK; Ho C; Prasad RN; Liu K; Upadhyay R; Klamer B; Wang J; Damante M; Ghose J; Blakaj DM; Beyer S; Grecula J; Arnett A; Thomas E; Chakravarti A; Lonser R; Hardesty D; Prevedello D; Prabhu R; Elder JB; Raval RR
    J Neurooncol; 2022 Sep; 159(2):389-395. PubMed ID: 35751740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases.
    Sharma M; Jia X; Ahluwalia M; Barnett GH; Vogelbaum MA; Chao ST; Suh JH; Murphy ES; Yu JS; Angelov L; Mohammadi AM
    Cancer Med; 2017 Sep; 6(9):2076-2086. PubMed ID: 28776956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.
    Boothe D; Young R; Yamada Y; Prager A; Chan T; Beal K
    Neuro Oncol; 2013 Sep; 15(9):1257-63. PubMed ID: 23814264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.
    Blonigen BJ; Steinmetz RD; Levin L; Lamba MA; Warnick RE; Breneman JC
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):996-1001. PubMed ID: 19783374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies.
    Kim JM; Miller JA; Kotecha R; Xiao R; Juloori A; Ward MC; Ahluwalia MS; Mohammadi AM; Peereboom DM; Murphy ES; Suh JH; Barnett GH; Vogelbaum MA; Angelov L; Stevens GH; Chao ST
    J Neurooncol; 2017 Jun; 133(2):357-368. PubMed ID: 28434110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator-based hypofractionated stereotactic radiosurgery for intact intracranial metastases.
    Zhang Q; Hamilton D; Conway P; Xie SJ; Haghighi N; Lasocki A
    J Med Imaging Radiat Oncol; 2023 Apr; 67(3):308-319. PubMed ID: 36847751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic radiation necrosis in brain metastasis patients treated with stereotactic radiosurgery and immunotherapy.
    Weingarten N; Kruser TJ; Bloch O
    Clin Neurol Neurosurg; 2019 Apr; 179():14-18. PubMed ID: 30784894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?
    Colaco RJ; Martin P; Kluger HM; Yu JB; Chiang VL
    J Neurosurg; 2016 Jul; 125(1):17-23. PubMed ID: 26544782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.